Readers' Comments on "Reassessing Smoore: Mistakes, Crisis, and the Way Forward"

Industry Insight by 2FIRSTS
Jan.04.2024
Readers' Comments on "Reassessing Smoore: Mistakes, Crisis, and the Way Forward"
2FIRSTS released an article titled "Reassessing Smoore: Mistakes, Crisis, and the Way Forward", sparking widespread discussion in the e-cigarette industry.

On January 3rd, 2FIRSTS published an in-depth article titled "Rethinking Smoore: Mistakes, crisis, and a way forward". The article immediately sparked widespread discussion within the e-cigarette industry.

 

2FIRSTS has conducted a comprehensive summary of various perspectives on the Smoore issue thus far. The aim is to provide readers with a more comprehensive viewpoint for further contemplation and discussion.

 

Below are the various perspectives: 

 

@migao: 

 

The missed opportunity in the disposable business and the late push with two major clients are closely related. Smoore mainly operates as an OEM business, meaning that no matter how great its technology is, it is in vain if customers do not utilize it. This inherent passivity in Smoore's role explains why it fell behind in the disposable market. Had BAT positioned themselves earlier in the disposable market, Smoore would have naturally kept up. After all, the technology required for disposable products is relatively low, and Smoore already possessed accumulated enough to meet the product demands.

 

Speculating further, it can be said that the tobacco industry in the UK and the US is not as quick to embrace disposables, not because they are unaware of the trend but rather because they are cautious about entering into cutthroat competition. Up until 2022, they may have held on to the hope that disposables would not gain popularity, considering the significant profit gap compared to pod-based systems. However, they eventually realized that they couldn't ignore the trend and had to personally engage in the market. Losing market share is more terrifying than sacrificing profits.

 

Therefore, based on the aforementioned points, it is not surprising that Smoore's lagging behind in the market carries a certain degree of expected sorrow.

 

The game of major client and the demand for optimizing supply chain costs for major clients have been clearly reflected in the past year in British American Tobacco and RELX. This year, British American Tobacco has placed 50% or even more of its disposable business with FirstUnion. Although they have introduced multiple new products this year, the main existing models and a new flagship model are now dominated by FirstUnion. This directly led to Smoore's failure to achieve its target of 4 billion in disposable business at the beginning of the year. If it had not been transferred to FirstUnion, Smoore's disposable business this year would have been around 50-60, but I estimate it will be around 35. RELX also experienced a similar situation, where the domestic market shifted from being solely supplied by Smoore to being shared by Smoore, FirstUnion, and ALD. As for the overseas market, I do not have the data, but I conservatively estimate that Smoore now accounts for less than 40%.

 

@Keepupthegoodwork:

 

The entire article fails to mention Smoore's compliance issues, such as PMTA, which is the fundamental reason why it has not entered the US market. In the European market, disposable companies have violated TPD rules by entering with a large number of products, which is also a significant reason why Smoore has not collaborated with these companies. Therefore, Smoore's current situation is largely due to various policy reasons, not its research and development efforts. Additionally, it should be noted that half of Smoore's research and development investment is allocated to HNB products, not solely disposable products, which the articles have failed to mention.

 

@999Roses:

 

In my impression, this seems to be the most detailed article analyzing Smoore. After reading it several times, I feel both disappointed by the setback of a giant and reassured by glimpses of hope. I am someone who believes in the power of time and believes in the order of the world. The road for e-cigarettes is still very long. The market will eventually move away from prioritizing growth data. At that time, the ultimate winner will be the one with the safest product and sufficient trust. There is a saying in the business world, "Don't compare who has a more glamorous life, but who can live longer." Yes, I believe Smoore is the company that will always be at the table.

 

Anonymous user:

 

Smoore has missed out on the best period of overseas development, which is both a strategic misjudgment and a result of their difficulty in ignoring external regulations. They are a company with long-term plans and have not made any fundamental mistakes in major decisions. However, China and overseas markets are two different playing fields, and therefore require two different approaches. Nevertheless, Smoore has once flourished, but it now appears increasingly quiet in the face of external capital speculation.

 

Anonymous User:

 

Smoore's investment is long-term and represents recognition of the regulatory trends surrounding e-cigarette compliance and the regulation of similar tobacco products. Due to requirements for compliance as a public company, Smoore cannot dramatically increase production orders. Additionally, as the tobacco industry is dominated by a few key players, Smoore must maintain strong relationships with these market leaders. In the short term, the e-cigarette market is not yet in a highly regulated era, so Smoore's second growth phase will not occur just yet. As a technology-driven company, Smoore must focus on iterating and innovating its vaporization technology, controlling factory costs, and betting on its new vaporization technology consumer products becoming popular. However, it is still too early to say whether these strategies will be successful.

 

It is even uncertain whether Smoore will remain standing until the day the mist clears.

 

An User on Xueqiu:

 

The analysis is sound, but it is unclear whether the author intentionally or unintentionally overlooked an important point - the importance of compliance and the impact of strong regulation on competition. RELX and Smoore's success was achieved in an environment without stringent regulation, which proved their capabilities as a manufacturer and brand. However, in the later years, the industry faced strong regulation, which noticeably affected major players like RELX and Smoore. On the other hand, new small and medium-sized manufacturers could take advantage of regulatory loopholes for penetration and development of new products, without facing the same restrictions. As a result, RELX and Smoore found themselves constrained within a very limited space, making the competition unequal. The decline in their market share, apart from not keeping up with e-cigarette consumer trends, can largely be attributed to this unfair competition. However, running fast doesn't guarantee running far. From a regulatory standpoint, e-cigarettes are burdened with "original sin." Therefore, compliance with regulations, legality, and ESG (Environmental, Social, and Governance) initiatives are the basic guarantees for companies to persist in the long run. RELX and Smoore possess much stronger capabilities in these aspects compared to other new players, although this often goes unnoticed.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds American, a BAT subsidiary, showcased four Vuse Pro flavored e-cigarette pods and its VELO nicotine pouch portfolio at NACS Show 2026. Booth staff confirmed to 2Firsts that the Vuse Pro flavors are sold in the U.S., although they have not received FDA marketing authorization. BAT outlined plans to expand Vuse retail distribution and reported that VELO held a 30.5% year-to-date volume share of the U.S. modern oral nicotine category through August 2026. The booth also featured the newly launched VELO MAX range and merchandising displays combining cigarettes, vaping products and oral nicotine brands.
EXPO
Oct.09
Latest UK ONS Data: Vaping Rate Edges Down to 9.9% in 2025, a Year After Overtaking Cigarette Smoking
Latest UK ONS Data: Vaping Rate Edges Down to 9.9% in 2025, a Year After Overtaking Cigarette Smoking
Vaping prevalence in Great Britain edged down to 9.9% in 2025 from 10.0% in 2024, with the number of adult users holding at approximately 5.4 million for a second consecutive year, according to the Office for National Statistics (ONS). E-cigarette use had risen from 6.4% in 2020 to 10.0% in 2024, when it exceeded cigarette smoking prevalence for the first time. Cigarette smoking continued to decline to 8.7% in 2025, widening the gap to 1.2 percentage points. Daily vaping declined slightly, while usage among adults aged 25–34 increased despite falling rates in other age groups.
DATA
Oct.14
China’s Vape-Related Exports Rose 4.5% in Q3 2026 as 21.6% Growth in Shipments to the UK Offset a Decline in Shipments to the US
China’s Vape-Related Exports Rose 4.5% in Q3 2026 as 21.6% Growth in Shipments to the UK Offset a Decline in Shipments to the US
China's vape-related exports rose 4.5% year over year to $2.86 billion in the third quarter of 2026, led by stronger shipments to the United Kingdom as exports to the United States declined. UK-bound shipments increased 21.6%, adding $81.9 million, while US exports fell 5.2%, or $53.6 million. Growth weakened through the quarter, with September exports down 6.3% globally and 37.8% to the US. Nicotine-containing vape products accounted for more than 82% of the quarterly net increase, while device exports were nearly flat. Nine-month exports totaled $7.82 billion, up 4.0%.
DATA
Oct.26
Los Angeles Cracks Down on Illicit Flavored Vapes and Counterfeit Goods: 12 Businesses Searched, 24 Arrested, Eight Truckloads Seized
Los Angeles Cracks Down on Illicit Flavored Vapes and Counterfeit Goods: 12 Businesses Searched, 24 Arrested, Eight Truckloads Seized
Los Angeles authorities searched 12 businesses and arrested 24 people during a multi-agency operation targeting illicit flavored vaping products, flavored cigarettes and counterfeit merchandise on October 22, 2026. The Los Angeles County Sheriff's Department said approximately eight tractor-trailer loads of merchandise were seized. Alleged violations involved flavored tobacco sales restrictions, tobacco licensing requirements and counterfeit trademark laws. Local, state and federal agencies participated. Authorities have not disclosed the number, brands or value of vaping products seized. Investigations remain ongoing.
Enforcement
Oct.28
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03